Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 8, 2025 • 10:00 AM ET

Date/Time Source News Release
05/29/2025 08:00 AM EDT GlobeNewswire Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
05/15/2025 07:00 AM EDT GlobeNewswire Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts
03/31/2025 07:00 AM EDT GlobeNewswire Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
03/19/2025 07:00 AM EDT Business Wire Cellares and Cabaletta Bio Successfully Complete Manufacturing Technology Adoption Program for Rese-cel Using the Cell Shuttle(TM) Platform
02/26/2025 08:00 AM EST GlobeNewswire Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference
02/18/2025 10:21 AM EST GlobeNewswire UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
02/18/2025 07:00 AM EST GlobeNewswire Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
02/11/2025 08:00 AM EST GlobeNewswire Cabaletta Bio Announces Presentations Featuring Updated Clinical Data on Rese-cel at Upcoming Scientific Meetings in February
01/29/2025 08:00 AM EST GlobeNewswire Cabaletta Bio to Participate in Guggenheim's SMID Cap Biotech Conference
01/13/2025 08:00 AM EST GlobeNewswire Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025
Page

Additional News

As of June 8, 2025 • 10:00 AM ET

Date/Time Source News Release
06/06/2025 11:09 AM EDT SeekingAlpha Autolus: A Buy Before Key Data Readout, Potential Expansion Into Autoimmune Market
05/17/2025 05:31 AM EDT US Earnings Reports Expected earnings - Cabaletta Bio Inc.
03/31/2025 07:57 AM EDT SeekingAlpha Cabaletta Bio GAAP EPS of -$0.65
03/27/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, March 27th, 2025
03/27/2025 05:30 AM EDT US Earnings Reports Expected earnings - Cabaletta Bio Inc.
03/20/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, March 20th, 2025
03/20/2025 05:30 AM EDT US Earnings Reports Expected earnings - Cabaletta Bio Inc.
01/06/2025 02:28 PM EST SeekingAlpha Cabaletta Bio: Finding Optimism In Dire Straits
11/14/2024 07:30 AM EST SeekingAlpha Cabaletta Bio GAAP EPS of -$0.62 misses by $0.03
11/14/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, November 14th, 2024
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.